ERBB2 and breast cancer: Using microdialysis-based sampling of interstitial solution from murine breast cancer tissue, we previously showed that NBCn1 knockout lowers lactate levels in highly glycolytic carcinogen-induced breast cancer [9] but has no effect in more moderately glycolytic ErbB2-induced breast cancer [10].